Exelixis Inc. buy Royal Bank of Canada
Start price
13.12.23
/
50%
€21.38
Target price
13.12.24
€24.09
Performance (%)
57.81%
End price
14.12.24
€33.74
Summary
This prediction ended on 14.12.24 with a price of €33.74. With a performance of 57.81% the BUY prediction by Royal_Bank_of_Canada was a big success. Royal_Bank_of_Canada has a follow-up prediction for Exelixis Inc. where he still thinks Exelixis Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 10.540% | 10.540% | 22.910% |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $26.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

